LDN193189(DM 3189) is a selective BMP signaling inhibitor, inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM, respectively, exhibits 200-fold selectivity for BMP versus TGF-
仅供研究使用。 我们不向患者出售。
化学信息
名称 | LDN193189 |
Iupac 化学名称 | 4-[6-(4-Piperazin-1-yl-phenyl)-pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline |
同义词 | LDN193189;LDN 193189;LDN-193189 |
英文同义词 | LDN193189;LDN 193189;LDN-193189 |
分子式 | C25H22N6 |
分子量 | 406.48 |
Smile | N1(CCNCC1)C1=CC=C(C=C1)C=1C=NC=2N(C1)N=CC2C2=CC=NC1=CC=CC=C21 |
InChiKey | CDOVNWNANFFLFJ-UHFFFAOYSA-N |
InChi | InChI=1S/C25H22N6/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2 |
Cas号 | 1062368-24-4 |
相关CAS号 | |
外观性状 | off-white solid |
纯度 | 98% |
存储 | -20 ºC for 3 years |
可溶性 | DMSO ��4mg/mL; Water ��30mg/mL; Ethanol <1mg/mL |
处理方式 | |
运输条件 | Shipped under ambient temperature |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |